Université de BordeauxCluster of excellence


OptoPath development followed two phases:

Phase 1 (2011-2016)
: Acquiring, and Developing new cutting-edge equipment that were not commercially available worldwide for in vivo behavioral and neurobiological investigations.

Phase 2 (starting in August 2016): Valorizing these new equipment and behavioral models through different main strategies:

  • Marketing the new cutting-edge instruments  which have been developed with Imetronic, our industrial partner